Physician profile
Morgan E Gary
NPI 1922659085
$4,941.75
in general payments reported to CMS, 2019-2025
35 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $855 · 2022: $1,339 · 2023: $1,792 · 2024: $576 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,028 · Travel and Lodging: $593 · Education: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,027.66 |
| Travel and Lodging | $593.05 |
| Education | $127.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,164.75 | 2022-2023 | Interstim |
| Abbvie INC. | $572.23 | 2022-2025 | |
| Teleflex LLC | $476.49 | 2021-2022 | |
| Janssen Biotech, INC. | $388.82 | 2021-2025 | Erleada |
| Edap Technomed INC | $379.13 | 2024-2025 | |
| Astellas Pharma US INC | $356.66 | 2021-2023 | Veozah, Myrbetriq, Xtandi |
| Allergan, INC. | $223.88 | 2021-2022 | |
| Antares Pharma, INC. | $168.53 | 2021-2023 | Nocdurna, Xyosted, Tlando |
| Tolmar, INC. | $109.70 | 2025 | Eligard, Jatenzo |
| Sumitomo Pharma America, INC. | $105.42 | 2023-2025 | Orgovyx, Gemtesa |
| Intuitive Surgical, INC. | $100.00 | 2024 | |
| 180 Medical, INC. | $86.52 | 2022-2024 | Cure Catheter |
| Axonics, INC. | $79.70 | 2021-2023 | Axonics |
| Urovant Sciences INC | $78.42 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $66.70 | 2021-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $61.16 | 2021-2023 | |
| Myovant Sciences INC. | $60.89 | 2021-2022 | |
| Olympus America INC. | $46.80 | 2024 | Itind System |
| Halozyme INC | $44.60 | 2023 | |
| Hollister Incorporated | $32.95 | 2021 | |
| Dendreon Pharmaceuticals LLC | $32.44 | 2021 | |
| Myriad Genetic Laboratories, INC. | $30.83 | 2022-2023 | Myrisk |
| Coloplast Corp | $28.09 | 2025 | |
| Acerus Pharmaceuticals Corporation | $26.18 | 2022 | |
| Endo Pharmaceuticals INC. | $25.30 | 2021 | |
| Immunitybio, INC. | $24.78 | 2024 | |
| Abc Home Medical Supply, INC. | $24.39 | 2025 | |
| Urogen Pharma, INC. | $24.07 | 2022 | |
| Convatec INC. | $23.44 | 2022 | |
| Ferring Pharmaceuticals INC. | $18.84 | 2025 | Adstiladrin |
| Pfizer INC. | $18.36 | 2024 | |
| Inspire Medical Systems, INC. | $17.65 | 2023 | Inspire |
| Procept Biorobotics Corporation | $15.48 | 2021 | |
| Alexion Pharmaceuticals, INC. | $14.62 | 2021 | |
| Rochester Medical Corporation | $13.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Gary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.